title: Whole abdominal external beam radiation in the treatment of primary carcinoma of the fallopian tube.
abstract: Thirty-two patients with adenocarcinoma of the fallopian tube, treated between 1975 and 1990, were studied. Thirteen patients had stage I disease, 9 stage II, and 10 stage III. All patients underwent bilateral salpingo-oophorectomy, total abdominal hysterectomy, and subcolic omentectomy. All patients received postoperative primary whole abdominal external beam radiotherapy. Seventeen patients (53.1%) of the treated group survived NED for at least 5 years. Survival was 76.9% for stage I, 55.6% for stage II, and 20% for stage III. In the Cox multivariate analysis, two variables were independently related to survival: stage of disease and size of residual disease after surgery. Postoperative teleradiotherapy was totally ineffective in gross residual (>2 cm in diameter) disease (0% 5-year NED survivors) and not effective enough in small residual disease (<2 cm in diameter) (33% 5-year NED survivors). Despite postoperative whole abdominal external beam radiotherapy, 3 patients with microscopic, 4 with small, and 4 with gross residual disease did fail within the peritoneal cavity.
authors.affiliation: Department of Gynecologic Oncology, Center of Oncology, Maria Skłodowska-Curie Memorial Institute, Kraków, Poland.
authors.forename: Z
authors.initials: Z
authors.lastname: Kojs
authors.forename: K
authors.initials: K
authors.lastname: Urbański
authors.forename: M
authors.initials: M
authors.lastname: Reinfuss
authors.forename: K
authors.initials: K
authors.lastname: Karolewski
authors.forename: M
authors.initials: M
authors.lastname: Klimek
authors.forename: J
authors.initials: J
authors.lastname: Pudełerk
authors.forename: J
authors.initials: J
authors.lastname: Mituś
mesh_terms: D000005:Abdomen; D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D000328:Adult; D000368:Aged; D005185:Fallopian Tube Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D017619:Hemibody Irradiation; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011182:Postoperative Care; D012189:Retrospective Studies; D015996:Survival Rate